Madurella mycetomatis Is Highly Susceptible to Ravuconazole

The current treatment of eumycetoma utilizing ketoconazole is unsatisfactory because of high recurrence rates, which often leads to complications and unnecessary amputations, and its comparatively high cost in endemic areas. Hence, an effective and affordable drug is required to improve therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Sarah Abdalla, Kloezen, Wendy, Duncanson, Frederick, Zijlstra, Ed E., de Hoog, G. Sybren, Fahal, Ahmed H., van de Sande, Wendy W. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063742/
https://www.ncbi.nlm.nih.gov/pubmed/24945848
http://dx.doi.org/10.1371/journal.pntd.0002942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063742/
https://www.ncbi.nlm.nih.gov/pubmed/24945848
http://dx.doi.org/10.1371/journal.pntd.0002942

Ejemplares similares